Therapeutic Areas: Infectious diseases incl. Covid-19

Choose Therapeutic Area
Infectious diseases incl. Covid-19
Rare diseases
Cromos Pharma provides a wide range of services to support the development of vaccines, treatments, and diagnostics for infectious diseases

We have a strong track record of supporting the development of drugs and therapies for various infectious diseases, including COVID-19.

Some of our key offerings and expertise include:

  • Clinical trial management: Cromos Pharma has extensive experience in managing clinical trials for infectious diseases. This includes designing and implementing clinical protocols, recruiting study participants, and collecting and analyzing clinical data.
  • Regulatory expertise: Cromos Pharma has deep understanding of the regulatory requirements for the development of vaccines, therapeutics, and diagnostics for infectious diseases. We can help companies navigate the regulatory landscape and ensure compliance with relevant guidelines and regulations.
  • Immunology expertise: Cromos Pharma has significant expertise in immunology, which is critical for the development of vaccines and therapies for infectious diseases. We can help companies implement immunological assays, interpret immunological data, and develop strategies for targeting specific immune responses.
  • In the case of COVID-19, Cromos Pharma has been instrumental in supporting the development of vaccines, therapeutics, and diagnostics. We have conducted vaccine trials, including mRNA vaccines and adenovirus-based vaccines. We have also supported the development of therapeutics, including monoclonal antibodies and antivirals.

Cromos Pharma’s expertise and offerings are particularly important in the context of evolving COVID-19 infection, where the development of effective interventions is critical for controlling the spread of the disease and saving lives.

Our experience in infectious diseases includes:
    • Candidiasis
    • Community-acquired pneumonia
    • COVID-19
    • Cytomegalovirus
    • Hepatitis B
    • HIV
    • Infectious diarrhea
    • Influenza
    • Nosocomial pneumonia
    • Respiratory Tract Infection
    • Sepsis
    • Skin and soft tissue infections
    • Tonsillitis
    • Tuberculosis
Cromos Pharma Infectious Diseases experience in the last five years
Clinical Sites
our Success story
An International Multicenter Randomized Double-blind Adaptive Placebo-controlled trial in Patients with Severe SARS-CoV-2 Virus Infection (COVID-19)
Click to openclose
Why Cromos Pharma
  • We are the only CRO to offer “No Patients, No Payment” risk sharing program, where the sponsor pays only if we deliver on our milestones.
  • We have the scientific and clinical expertise to support your clinical studies, from early to late phase, from single- to multi-country execution strategies.
  • By leveraging our international expertise, we deliver unparalleled results through diligent feasibility analysis, rapid startup, and accelerated recruitment, while utilizing proactive risk management strategies and maintaining the highest data quality.
  • Our team has vast expertise in organizing scientific advisory board meetings of key opinion leaders, clinicians, and industry stakeholders.



more therapeutics